Biogen cuts the price tag on its Alzheimer's drug in half
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
Source: ncadvertiser.com
📰 Aduhelm News
Page 17 - Aduhelm News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aduhelm. Real-time updates on events, politics, business and more.
Biogen halves price of controversial Alzheimer's drug
Biogen on Monday cut in half the price of its Alzheimer's drug Aduhlem in an effort to boost lackluster sales that stemmed in part from controversy over its price.
Source: thehill.com
Biogen Halves Price of Alzheimer's Drug to $28,200
Biogen Inc. on Monday cut the price of its Alzheimer's drug by about half to $28,200 for an ...
Source: theepochtimes.com
Aducanumab rejected in the EU: Biogen will ask EMA to re-examine application
Biogen will ask the European Medicines Agency (EMA) to re-examine its Alzheimer’s drug application, following the agency’s recommendation to refuse authorization of the drug in the EU.
Source: biopharma-reporter.com
Biogen cuts the price tag on its Alzheimer's drug in half
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
Source: ctpost.com
Biogen cuts the price tag on its Alzheimer's drug in half
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
United Kingdom United States Michel Vounatsos Brian Abrahams Japan Eisai Co European Medicines Agency
Source: theridgefieldpress.com
Biogen cuts the price tag on its Alzheimer's drug in half
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
Source: trumbulltimes.com
Biogen cuts the price tag on its Alzheimer's drug in half
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
United Kingdom United States Michel Vounatsos Brian Abrahams Japan Eisai Co European Medicines Agency
Source: darientimes.com
Biogen Cuts the Price Tag on Its Alzheimer's Drug in Half
Biogen is slashing the price of its Alzheimer’s treatment months after the drug debuted to widespread criticism for an initial cost that can reach $56,000...
United Kingdom United States Michel Vounatsos Brian Abrahams Japan Eisai Co European Medicines Agency
Source: nbcmiami.com
Biogen slashes price of Alzheimer's drug by half as CMS coverage decision looms
The price of Biogen Alzheimer’s disease drug Aduhelm will be cut in half at the start of 2022, a move that comes as a Medicare recommendation on coverage is expected early next year. Meanwhile, Biogen is preparing corporate measures projected to save $500 million annually, cost-cutting made necessary in part due to slow market uptake of Aduhelm.
United States Michel Vounatsos Institute For Clinical European Medicines Agency Medicaid Services Economic Review
Source: medcitynews.com